AURKA and cancer: To this aim, we decided to choose AURKA protein as a representative switch among those identified because this kinase: (i) regulates cell division and cell-cycle progression; (ii) is deregulated in many human cancers; (iii) is suggested as a priority pharmaceutical target for the treatment of cancers [18]; and (iv) are known and validated its specific inhibitors [19,20,21].